Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0447
Source ID: NCT01988116
Associated Drug: Oral Calcitriol 0.5 Mcg Once Daily For 6 Weeks
Title: Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Anemia of Chronic Disease
Interventions: DRUG: Oral Calcitriol 0.5 mcg once daily for 6 weeks|DRUG: Placebo
Outcome Measures: Primary: Change in serum hepcidin levels, At Day 0, Day 3, 1 week, 4 weeks and 6 weeks|Change in soluble hemojuvelin, At Day 0, Day 3, 1 week, 4 weeks and 6 weeks|Change in other indices of iron metabolism, Including, Serum Ferritin, Iron level, Percent transferrin saturation and TIBC, At Day 0, Day 3, 1 week, 4 weeks and 6 weeks | Secondary: Change in serum hemoglobin, At Day 0, Day 3, 1 week, 4 weeks and 6 weeks
Sponsor/Collaborators: Sponsor: University of Alabama at Birmingham
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: EARLY_PHASE1
Enrollment: 40
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Start Date: 2013-10
Completion Date: 2015-06
Results First Posted:
Last Update Posted: 2015-08-24
Locations: University of Alabama, Birmingham, Alabama, 35294, United States
URL: https://clinicaltrials.gov/show/NCT01988116